Game Creek Capital, LP Biogen Inc. Transaction History

Game Creek Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $268,840 - $350,597	-950 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $246,050 - $393,974	950 New	950 $329,000
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $8.61 Million - $12.2 Million	-33,109 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $10.2 Million - $11.4 Million	33,109	33,109 $0

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Game Creek Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Game Creek Capital, LP with notifications on news.